1. Home
  2. VBNK vs SLN Comparison

VBNK vs SLN Comparison

Compare VBNK & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VBNK
  • SLN
  • Stock Information
  • Founded
  • VBNK 1980
  • SLN 1994
  • Country
  • VBNK Canada
  • SLN United Kingdom
  • Employees
  • VBNK N/A
  • SLN N/A
  • Industry
  • VBNK Commercial Banks
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VBNK Finance
  • SLN Health Care
  • Exchange
  • VBNK Nasdaq
  • SLN Nasdaq
  • Market Cap
  • VBNK 381.9M
  • SLN 352.2M
  • IPO Year
  • VBNK 2021
  • SLN N/A
  • Fundamental
  • Price
  • VBNK $13.58
  • SLN $6.88
  • Analyst Decision
  • VBNK Strong Buy
  • SLN Strong Buy
  • Analyst Count
  • VBNK 3
  • SLN 4
  • Target Price
  • VBNK $19.00
  • SLN $61.50
  • AVG Volume (30 Days)
  • VBNK 204.4K
  • SLN 691.1K
  • Earning Date
  • VBNK 12-09-2024
  • SLN 11-14-2024
  • Dividend Yield
  • VBNK 0.54%
  • SLN N/A
  • EPS Growth
  • VBNK N/A
  • SLN N/A
  • EPS
  • VBNK 1.07
  • SLN N/A
  • Revenue
  • VBNK $80,302,117.00
  • SLN $21,773,221.00
  • Revenue This Year
  • VBNK N/A
  • SLN N/A
  • Revenue Next Year
  • VBNK $34.02
  • SLN $104.98
  • P/E Ratio
  • VBNK $12.58
  • SLN N/A
  • Revenue Growth
  • VBNK 3.59
  • SLN N/A
  • 52 Week Low
  • VBNK $9.48
  • SLN $5.81
  • 52 Week High
  • VBNK $18.38
  • SLN $27.72
  • Technical
  • Relative Strength Index (RSI)
  • VBNK 32.03
  • SLN 32.78
  • Support Level
  • VBNK $12.98
  • SLN $5.96
  • Resistance Level
  • VBNK $14.13
  • SLN $8.88
  • Average True Range (ATR)
  • VBNK 0.89
  • SLN 0.73
  • MACD
  • VBNK -0.49
  • SLN 0.27
  • Stochastic Oscillator
  • VBNK 11.57
  • SLN 33.77

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. VersaBank became the world's first digital financial institution when it adopted its highly efficient business-to-business model using its proprietary state-of-the-art financial technology to profitably address underserved segments of the Canadian banking market in the pursuit of superior net interest margins, while mitigating risk. VersaBank obtains all of its deposits and provides the majority of its loans and leases electronically, with innovative deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, VersaBank established a wholly-owned, subsidiary.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

Share on Social Networks: